Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047)
-
Published:2024-08
Issue:
Volume:194
Page:107894
-
ISSN:0169-5002
-
Container-title:Lung Cancer
-
language:en
-
Short-container-title:Lung Cancer
Author:
Asao TetsuhikoORCID,
Shukuya TakehitoORCID,
Uemura Kohei,
Kitadai RuiORCID,
Yamamoto Gaku,
Mouri Atsuto,
Tamaoka Meiyo,
Imai Ryosuke,
Tsukita YokoORCID,
Isobe KazutoshiORCID,
Watanabe SatoshiORCID,
Kamimura Mitsuhiro,
Morita Ryo,
Kudo Keita,
Inomata MinehikoORCID,
Tateishi KazunariORCID,
Kakinuma Kazutaka,
Yoshioka HiroshigeORCID,
Namba YukikoORCID,
Sumiyoshi Issei,
Nakagawa TakuORCID,
Watanabe KanaORCID,
Kobayashi Kunihiko,
Takahashi Kazuhisa